{"name":"ACTAVIS LABS UT INC","slug":"actavis-labs-ut-inc","ticker":"","exchange":"","domain":"actavislabsut.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1976-01-01","label":"Butalbital, Aspirin And Caffeine first approved","drug":"Butalbital, Aspirin And Caffeine","drugSlug":"butalbital","type":"approval","sentiment":"positive"},{"date":"1990-01-01","label":"Condylox first approved","drug":"Condylox","drugSlug":"podophyllotoxin","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Butalbital, Aspirin And Caffeine","genericName":"BUTALBITAL","slug":"butalbital","indication":"Tension-type headache","status":"marketed"},{"name":"Condylox","genericName":"podophyllotoxin","slug":"podophyllotoxin","indication":"Topical treatment of anogenital warts","status":"marketed"}]}],"pipeline":[{"name":"Butalbital, Aspirin And Caffeine","genericName":"BUTALBITAL","slug":"butalbital","phase":"marketed","mechanism":"GABA-A receptor alpha-1/beta-3/gamma-2","indications":["Tension-type headache"],"catalyst":""},{"name":"Condylox","genericName":"podophyllotoxin","slug":"podophyllotoxin","phase":"marketed","mechanism":"Condylox works by disrupting cell division and preventing the growth of abnormal cells.","indications":["Topical treatment of anogenital warts"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}